Click it and Unblock the Notifications
Latest Updates
-
Amitabh Bachchan's Misunderstood Blog Sparked Concern, But His Real Medical Battles Define Resilience -
Jaipur Ranks 6th Among World's Happiest Cities 2026: The Culture Behind The Joy -
Why Green Is the Colour of Sawan: History, Symbolism, and Styling Tips -
Legionnaires' Disease Outbreak: What It Is, Symptoms, Causes, And Prevention Explained -
Ananya Panday's Gaurav Gupta Couture Featured 12,000 Pearls, 2,600 Petals And A Celestial Love Story -
Kharchi Puja 2026: Tripura's Ancient Festival Where The Heads Of Fourteen Deities Are Worshipped -
World Brain Day 2026: How Quality Sleep Helps Safeguard Your Brain Health -
National Mango Day 2026: Why Mango Is Called The 'King Of Fruits' And What Sets It Apart -
Is It Monsoon Hair Fall Or Something More Serious? How To Tell -
World Brain Day 2026: Date, History, Theme, and Why It Matters
Potential Therapeutic Targets For Cystic Fibrosis
Cystic Fibrosis is the condition which leads to the progressive disorders in the functioning of lungs and pancreas. It may also cause gastrointestinal obstruction or blockage. The defective signalling of a protein, called Peroxisome Proliferator Activated Receptor (ppar) causes the severity of cystic fibrosis.
So the symptoms of the disease can be reduced to an extent, if the defective signalling of ppar is corrected.
The research also reveals that the defect in the signalling of ppar is resulted by the reduced levels of prostaglandins which activate the receptor. The studies are done by the scientists from San Diego School of Medicine affiliated to the University of California.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.
Continue with Google